Clinical Trials

Showing trials with last updates posted in 2026.

NCT06161532 | RECRUITING | PHASE2
60 participants

Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile C...

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-13
Start Date:
2024-08-01
Completion:
2027-11-01
Conditions
  • Small Cell Carcinoma of the Bladder
  • Small Cell Carcinoma of the Urinary Tract
  • Squamous Cell Carcinoma of the Bladder
  • Squamous Cell Carcinoma of the Urinary Tract
  • Primary Adenocarcinoma of the Bladder
  • Primary Adenocarcinoma of the Urinary Tract
  • Renal Medullary Carcinoma
  • Squamous Cell Carcinoma of the Penis
Interventions
  • DRUG
No Results Yet
NCT06154174 | ACTIVE_NOT_RECRUITING | NA
1500 participants

Choline to Improve Malnutrition and Enhance Cognition

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-13
Start Date:
2023-12-05
Completion:
2027-01-31
Conditions
  • Severe Acute Malnutrition
  • Cognitive Impairment
  • Wasting
  • Kwashiorkor
Interventions
  • DIETARY_SUPPLEMENT
  • DRUG
No Results Yet
NCT05985655 | RECRUITING | PHASE1/PHASE2
230 participants

Study to Assess GTAEXS617 in Participants With Advanced Solid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-13
Start Date:
2023-07-06
Completion:
2028-01-31
Conditions
  • Head and Neck Squamous Cell Carcinoma (HNSCC)
  • Pancreatic Adenocarcinoma
  • Non-small Cell Lung Cancer (NSCLC)
  • Platinum-resistant High-grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers (HGSOC)
  • Hormone Receptor Positive [HR+] and Human Epidermal Growth Factor Receptor 2 Negative [HER2-] Breast Carcinoma
  • Triple Negative Breast Cancer (TNBC)
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page